The successful application of CRISPR genome editing depends on the accurate assembly of the sgRNA-Cas protein complex which forms the ribonucleoprotein (RNP) complex. BOC Sciences specializes in producing superior quality RNP complexes which enable precise gene editing for numerous biological applications. We provide a synthesis service for sgRNA and Cas protein complexes that delivers unmatched stability and efficiency while maintaining compatibility with different cell types and delivery approaches to meet researchers' genome editing requirements.
To initiate your sgRNA and Cas9 complex - ribonucleoprotein (RNP) synthesis request, please follow these steps:
A ribonucleoprotein (RNP) is a molecular complex composed of RNA molecules bound to proteins, playing essential roles in numerous biological processes. In the context of CRISPR-Cas systems, an RNP consists of a guide RNA (sgRNA) and a Cas nuclease, forming a fully functional editing complex that can be directly delivered into cells. Unlike plasmid-based or viral delivery approaches, RNP complexes provide immediate editing activity, reduce the risk of unwanted genomic integration, and improve safety profiles for gene-editing applications.
The sgRNA-Cas9 complex is the core machinery of CRISPR-mediated genome editing. The key functions include:
This mechanism makes the sgRNA-Cas9 RNP complex a powerful and versatile tool for precise genetic modifications.
BOC Sciences provides a comprehensive suite of services related to the synthesis, optimization, and customization of sgRNA and Cas protein complexes (RNPs) to support diverse genome-editing applications. Our specialized services ensure high efficiency, precision, and scalability for researchers working in functional genomics, gene therapy, and biotechnological applications.
Our sgRNA synthesis service covers the design, chemical modification, and large-scale production of high-purity, sequence-specific sgRNAs optimized for CRISPR-Cas9, Cas12, and Cas13 systems.
(1) 2′-O-methyl (2′-OMe) modifications to increase RNA stability.
(2) Phosphorothioate (PS) linkages to enhance resistance to exonucleases.
(3) Chimeric RNA-DNA modifications to optimize binding efficiency.
We offer an extensive range of Cas nucleases to meet diverse genome-editing needs. Each Cas protein is produced under stringent purification and activity validation protocols, ensuring high enzymatic efficiency and minimal contaminants.
To maximize genome-editing efficiency, we provide pre-assembled, functionally validated RNP complexes ready for direct delivery into cells. Our RNP assembly services include.
(1) Gel shift assays (EMSA) to confirm sgRNA-Cas binding.
(2) In vitro cleavage assays to verify enzymatic activity.
(3) Cell-based editing assays to ensure precise genome modifications.
Our streamlined workflow ensures the highest quality and reproducibility of RNP complexes, tailored to meet specific research and application needs.
With this meticulously optimized workflow, BOC Sciences delivers high-performance, ready-to-use RNP complexes, ensuring superior genome-editing outcomes for diverse research applications.
With this systematic and quality-driven workflow, BOC Sciences guarantees highly efficient and precisely designed pegRNAs that empower researchers to push the boundaries of genome editing.
Years of experience in nucleic acid chemistry and protein engineering.
Fully customized sgRNA sequences and Cas protein formulations for diverse CRISPR applications.
Rigorous quality control ensures batch-to-batch consistency.
Pre-assembled RNPs eliminate the need for in-house preparation, reducing experimental variability.
Capabilities ranging from small-scale research needs to large-scale biopharmaceutical manufacturing.
Dedicated technical support for experimental design and troubleshooting.
Our sgRNA and Cas Protein Complex - Ribonucleoprotein (RNP) Synthesis Service is widely used across multiple research fields, providing precise and efficient genome editing solutions. The versatility and high efficiency of RNP-mediated editing make it an essential tool in various applications, including functional genomics, gene therapy research, synthetic biology, and biopharmaceutical development.
RNP complexes facilitate the efficient disruption of specific genes to investigate their function. By introducing targeted double-strand breaks (DSBs), researchers can induce frameshift mutations through non-homologous end joining (NHEJ), leading to gene inactivation. This approach is widely used in studying disease models, regulatory pathways, and cellular functions.
For researchers aiming to introduce precise modifications, RNPs can be used in conjunction with homology-directed repair (HDR) templates to insert specific DNA sequences at designated genomic loci. This technique is essential for applications such as disease modeling, functional protein tagging, and correction of genetic mutations.
Beyond traditional CRISPR-mediated DSBs, RNPs are integral to base editing and prime editing technologies, which enable single-nucleotide conversions without introducing breaks in the DNA. This application is particularly beneficial for correcting point mutations associated with genetic disorders or introducing precise modifications in a controlled manner.
Stable gene modifications in mammalian cell lines and animal models are crucial for biomedical research. Our high-purity RNP complexes support efficient genome editing in various systems, including stem cells, primary cells, and in vivo models such as zebrafish, mice, and non-human primates. This application is critical for studying disease mechanisms, drug screening, and regenerative medicine research.
RNP-based gene editing is widely adopted in ex vivo cell engineering, particularly in immune cell therapies (e.g., CAR-T and CAR-NK development). The transient nature of RNP delivery ensures precise modifications without the risk of genomic integration, making it a safer alternative to plasmid or viral-based systems for therapeutic applications.
RNPs offer higher editing efficiency, faster action, lower off-target effects, and no risk of genomic integration, making them ideal for sensitive applications, including clinical research.
Yes, we offer fully customized RNP complexes, including target-specific sgRNA design and optimization. Simply provide your target sequence, and we will handle the synthesis and assembly.
Each RNP complex undergoes rigorous quality control, including sgRNA integrity analysis, Cas protein purity assessment, and functional validation in gene editing assays. This ensures high specificity and efficiency in your experiments.
Yes, our RNP complexes are optimized for use in various cell types, including hard-to-transfect primary cells and stem cells. We also offer customized formulations to enhance delivery efficiency.
Yes, we offer a range of CRISPR-associated nucleases, such as Cas12a and high-fidelity Cas9 variants. If you need a specific nuclease, we can accommodate custom requests.
Yes, we provide guidance on electroporation, lipofection, and microinjection techniques to maximize RNP delivery efficiency. Our team can also recommend delivery reagents and protocols tailored to your cell type.
BOC Sciences is committed to delivering cutting-edge RNP synthesis solutions with uncompromising quality and efficiency. Contact us today to accelerate your CRISPR research with our high-performance sgRNA and Cas Protein Complex - Ribonucleoprotein (RNP) Synthesis Service.